Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Yourgene Health plc (YGEN) Ordinary Shares 0.1p

Sell:20.00p Buy:21.00p 0 Change: No change
Market closed Prices as at close on 30 September 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:20.00p
Buy:21.00p
Change: No change
Market closed Prices as at close on 30 September 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:20.00p
Buy:21.00p
Change: No change
Market closed Prices as at close on 30 September 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Yourgene Health PLC, formerly Premaitha Health PLC, is engaged in molecular diagnostics business for research into, and the development and commercialization of gene analysis techniques for pre-natal screening and other clinical applications in the early detection, monitoring and treatment of disease. The Company's product, the IONA test is a non-invasive in vitro diagnostic product for prenatal screening enabling clinical laboratories to offer a regulated non-invasive prenatal test in-house. The IONA test estimates the risk of a fetus having Down's syndrome or other serious genetic diseases. The risks that fetus may be affected with include Trisomy 21 (Down's syndrome), Trisomy 18 (Edwards' syndrome), Trisomy 13 (Patau's syndrome) and Fetal sex determination optional. The analysis is performed on cell-free placental deoxyribonucleic acid (DNA) from a maternal blood sample, with test results available in three days turnaround time.

Contact details

Address:
Enterprise House, Lloyd Street North
MANCHESTER
M15 6SE
United Kingdom
Telephone:
+44 (0161) 6676865
Website:
https://www.premaitha.com/

Important dates

Future events
There are no future events available.
Past events
AGM 22 September 2020 22/09/20
Final results 28 July 2020 28/07/20
Annual report 28 July 2020 28/07/20
Trading Announcement 26 May 2020 26/05/20
Trading Announcement 20 April 2020 20/04/20
Interim results 02 December 2019 02/12/19
Trading Announcement 14 October 2019 14/10/19

General stock information

EPIC:
YGEN
ISIN:
GB00BN31ZD89
Market cap:
£147.70 million
Shares in issue:
719.51 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Lyn Rees
    Chief Executive Officer
  • Stephen Little
    Executive Vice Chairman of the Board
  • Barry Hextall
    Chief Financial Officer, Director
  • Keng Hsu
    Chief Operating Officer
  • William Denman
    Executive Director
  • Hayden Jeffreys
    Group Commercial Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.